Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Elanco Animal HealthMEX:ELAN 66 EV-to-FCF is 48.17 as of Jul. 14, 2026, which is 21% above its 10-year median of 39.69. GuruFocus rates MEX:ELAN with a GF Score™ of 66/100 and a GF Value™ of MXN246.22. The stock has 5 warning signs investors should review. Among 562 Drug Manufacturers companies, Elanco Animal Health ranks worse than 73.84% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Elanco Animal Health's Enterprise Value is MXN282,393 Mil.
Elanco Animal Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was MXN5,862 Mil. Therefore, Elanco Animal Health's EV-to-FCF for today is 48.17.
The historical rank and industry rank for Elanco Animal Health's EV-to-FCF or its related term are showing as below:
MEX:ELAN'
s EV-to-FCF Range Over the Past 10 Years
Min: -261.55 Med: 39.69 Max: 1279.85
Current: 50.66
During the past 11 years, the highest EV-to-FCF of Elanco Animal Health was 1279.85. The lowest was -261.55. And the median was 39.69.
MEX:ELAN's EV-to-FCF is ranked worse than 73.84% of 562
companies
in the Drug Manufacturers industry
Industry Median: 20.955
vs MEX:ELAN: 50.66
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Elanco Animal Health (MEX:ELAN) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Elanco Animal Health's PE Ratio (TTM) for today is calculated as:
Elanco Animal Health's share price for today is MXN392.00.
Elanco Animal Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-9.079.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Elanco Animal Health EV-to-FCF Related Terms
Elanco Animal Health EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Elanco Animal Health's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:ELAN vs ALKS, HIMS, NBIX: EV-to-FCF Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Elanco Animal Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elanco Animal Health EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Elanco Animal Health's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Elanco Animal Health's EV-to-FCF falls into.
Elanco Animal Health's current Enterprise Value is MXN282,393 Mil.
Elanco Animal Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN5,862 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elanco Animal Health (MEX:ELAN) has a EV-to-FCF of 48.17 as of Jul. 14, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Elanco Animal Health and its competitors. This is 21% above median its historical median of 39.69. According to the industry distribution chart, Elanco Animal Health ranks #415 out of 562 companies in the Drug Manufacturers industry, placing it in the top 73.8%.
Is Elanco Animal Health's EV-to-FCF too high?
Elanco Animal Health's current EV-to-FCF of 48.17 is 21% above median its 10-year median of 39.69. The Drug Manufacturers industry median EV-to-FCF is 20.96. Elanco Animal Health's value of 48.17 is 129.9% above this industry median. Based on the distribution chart, Elanco Animal Health ranks #415 out of 562 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Elanco Animal Health has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Elanco Animal Health's EV-to-FCF compare to ALKS and HIMS?
According to the Drug Manufacturers industry distribution chart, Elanco Animal Health ranks #415 out of 562 companies for EV-to-FCF. This places Elanco Animal Health in the lower half of its industry. The industry median EV-to-FCF is 20.96. Elanco Animal Health's value of 48.17 is 129.9% above this benchmark. While the company's 10-year median is 39.69 vs. the industry median of 20.96, Elanco Animal Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.96, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elanco Animal Health's current EV-to-FCF of 48.17 is 129.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Elanco Animal Health and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elanco Animal Health's current EV-to-FCF is 48.17, which is 21% above median its own 10-year median of 39.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elanco Animal Health stock overvalued right now?
Elanco Animal Health (MEX:ELAN) has a current EV-to-FCF of 48.17. The stock's GF Value™ is MXN246.22, compared to a current price of MXN392.00 — trading 59.2% above its estimated fair value. The current EV-to-FCF is 48.17, which is 21% above median its 10-year median of 39.69 and 129.9% above the Drug Manufacturers industry median of 20.96. Elanco Animal Health's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Elanco Animal Health (MEX:ELAN), the current EV-to-FCF is 48.17 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elanco Animal Health (MEX:ELAN) Overvalued in 2026?
Based on GuruFocus' analysis, Elanco Animal Health stock appears to be overvalued.
The current stock price of MXN392.00 is trading 59.2% above its estimated GF Value™ of MXN246.22.
Key valuation signals for MEX:ELAN:
EV-to-FCF: 48.17 (21% above median its 10-year median of 39.69)
GF Value™: MXN246.22 vs. price of MXN392.00 (59.2% above fair value)
Industry Position: 129.9% above the Drug Manufacturers median (#415 of 562)
No single metric tells the full story. See the MEX:ELAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
66GF Score
Get the complete analysis for MEX:ELAN
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ELAN has been successfully added to your 
